Cardiorenal Protection in Heart Failure: Role of SGLT2 Inhibition

City
Webinar
Type of event
virtual

Invitation

Dear Dr.

The Zurich Heart House would like to invite you to a special webinar on

Cardiorenal Protection in Heart Failure: Role of SGLT2 Inhibition

Date: Thursday, May 5th, 2022, 17:00 – 18:30 CET

We are looking forward to meeting you during this webinar.

Thomas F. Lüscher, Zurich and London
Roger Hullin, Lausanne

Organized by

 

logo-zhh_quer.png

 

qrcode_newsletter05.05.2022.png

 

Programme

Moderation: Roger Hullin, Lausanne and Thomas F. Lüscher, London/Zurich

17:00 Introduction                                  
17:05 Lessons learned from DAPA-HF and DAPA-CKD Michael Böhm, Homburg/Saar
17:25 Cardiorenal benefits: what’s relevant for the cardiologist                   Wilfried Mullens, Genk
17:45 SGLT2i in Heart Failure: how to implement guidelines into clinical practice Mark Petrie, Glasgow
18:05 Panel discussion Faculty
18:30 End of symposium  

This programme is supported by AstraZeneca.
The scientific programme has not been influenced in any way by its sponsor. 

Accreditation

This webinar has been granted 1 European CME credits by the European Accreditation Council for Continuing Medical Education (EACCME®).